Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for central neuropathic pain in multiple sclerosis
2006-004255-38Phase 3Completed
- Sponsor
- Bionorica
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) and central neuropathic pain (CNP) comparing Dronabinol with Placebo (2 arms). Primary endpoint: Change in chronic pain severity on 11-point NRS. Started Nov 2006; status: completed.
02
Drugs
dronabinol
03
Conditions
multiple sclerosis (MS)central neuropathic pain (CNP)
Beyond the preview
Go deeper on 2006-004255-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004255-38.